UltraPharmRx
UltraPharmRx is a private direct-to-consumer telehealth platform operating in 48 US states, connecting men with licensed physicians for online prescriptions of generic ED, hair loss, testosterone, and custom Fixed-Dose Combination medications delivered from a US-based pharmacy.
- Company typePrivate
- Founded2010
- HeadquartersMassapequa Park, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What UltraPharmRx does
UltraPharmRx is a privately held direct-to-consumer telehealth company that connects patients in 48 US states with US-licensed, board-certified physicians for the online prescription and home delivery of generic men's health medications. Founded in 2010 and headquartered in Massapequa Park, New York (with a corporate office in Melville, NY), the company employs 11-50 people and operates a 100% online platform where customers complete a roughly 3-minute health questionnaire, receive asynchronous physician review (with synchronous video required in NH, DE, LA, NJ, NM, WV, ID), and obtain prescriptions filled by a US-based licensed pharmacy and shipped via USPS. The active product portfolio is concentrated in erectile dysfunction (Generic Viagra/Sildenafil, Generic Cialis/Tadalafil) and hair loss (Finasteride), with testosterone enhancement, custom Fixed-Dose Combination medications, and weight loss treatments listed as forthcoming.
The underlying technology is a conventional asynchronous telemedicine platform integrating patient intake, physician review, electronic prescribing, and pharmacy fulfillment, supplemented by subscription/auto-renewal billing. The company is differentiated by custom Fixed-Dose Combination (FDC) medications developed exclusively for its customer base — branded as Alpha Protocol, Magnum Protocol, and Shred Protocol — that combine multiple active ingredients to target several physiological pathways simultaneously. Compliance infrastructure includes HIPAA business-associate practices, CCPA disclosures for California residents, and LegitScript certification. Customer data is a 3-minute online intake form, with no machine-learning-driven personalization layer described in the source.
The business model is subscription-based DTC e-commerce priced at $1.75 per pill or from $16 per month, with customers billed only after physician approval and no insurance required. Revenue is generated by the recurring sale of prescription medications (generic Sildenafil and Tadalafil being the highest-volume products) and by proprietary FDC protocols. Marketing and customer acquisition are entirely digital, spanning paid advertising on Google, Facebook, Bing, and Criteo, organic content marketing via a men's health blog, and active social media presence across Facebook, Twitter, YouTube, Instagram, TikTok, and LinkedIn. UltraPharmRx does not require insurance, does not bill in-person clinical visits, and ships medications in discreet packaging via USPS First Class Mail with free rushed shipping. No parent company, outside funding, or institutional investors are disclosed.
UltraPharmRx firmographics
Firmographics- Name
- UltraPharmRx
- Legal name
- UltraPharmRx
- Website
- https://ultrapharmrx.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- UltraPharmRx is a private direct-to-consumer telehealth platform operating in 48 US states, connecting men with licensed physicians for online prescriptions of generic ED, hair loss, testosterone, and custom Fixed-Dose Combination medications delivered from a US-based pharmacy.
- Ownership category
- akta.pro rank
UltraPharmRx industry classification
Industry- Product category
- Telehealth Men's Health Services
- NAICS
- Offices of Physicians (62111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)
- akta.pro secondary industry
- Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG)
Keywords
Where UltraPharmRx is headquartered
LocationHeadquarters
- HQ city
- Massapequa Park
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
UltraPharmRx business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
Revenue model
- Prescription Medication Sales: UltraPharmRx generates revenue through the sale of prescription medications for erectile dysfunction, hair loss, and testosterone treatments. The company uses an automatic renewal subscription model where customers are charged on a recurring basis. Payment is processed only after prescription approval by a physician. The service includes US-made, FDA-approved generic medications (Generic Viagra/Sildenafil and Generic Cialis/Tadalafil) as well as branded options.
- Custom Treatment Plans: Revenue generated from personalized treatment plans including proprietary Fixed-Dose Combination medications developed exclusively for UltraPharmRx customers. These include Alpha Protocol (Testosterone Enhancement), Magnum Protocol (Sexual Enhancement), and Shred Protocol (Weight Loss).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Entry-level prescription medication plans starting at $16 per month |
| Unit Pricing | Pay-as-you-go | Per-pill pricing for prescription ED medications |
| Subscription | Monthly | Discounted first-time customer offer with free shipping |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
UltraPharmRx product offering
Product offeringCore offering
UltraPharmRx is a direct-to-consumer telehealth platform that connects patients in the United States with US-licensed, board-certified physicians for online consultations and prescription treatments focused on men's health conditions, including erectile dysfunction, hair loss, and low testosterone. Customers complete a 3-minute online health questionnaire, receive physician review, and obtain FDA-approved generic medications that are dispensed by a US-based pharmacy and shipped directly to their homes. Custom Fixed-Dose Combination (FDC) medications are developed exclusively for UltraPharmRx customers to target multiple treatment pathways.
Product overview
UltraPharmRx is a digital telehealth platform providing men's health treatments through a 100% online healthcare system. The core offering combines a telehealth consultation platform with prescription medications dispensed by a US-based pharmacy. The product portfolio centers on FDA-approved generic medications for erectile dysfunction (Generic Viagra/Sildenafil, Generic Cialis/Tadalafil), hair loss treatments (Finasteride), and testosterone enhancement (Enclomiphene, Alpha Protocol). Additional offerings include sexual enhancement protocols (Magnum Protocol), weight loss treatments (Shred Protocol), and custom Fixed-Dose Combination medications developed exclusively for customers. All treatments require an online health questionnaire reviewed by board-certified physicians before prescription approval. Services are available in 48 US states, with pricing starting at $1.75 per pill and monthly plans beginning at $16.
Differentiator
Problem solved
Functional benefit
Brands
- Generic Viagra (Sildenafil Citrate): FDA-approved generic erectile dysfunction medication featuring sildenafil citrate.
- Generic Cialis (Tadalafil)
- Finasteride (Generic Propecia)
- Enclomiphene (Generic Androxal)
- Alpha Protocol
- Magnum Protocol
- Shred Protocol
Products and services
- Generic Viagra (Sildenafil Citrate)
- Generic Cialis (Tadalafil)
- Finasteride (Generic Propecia)
- UltraPharmRx Telehealth Platform
Quantifiable outcome
- Save up to 90% with generic medications vs. brand-name counterparts
- +3 more outcomes
Companies that use UltraPharmRx
Customer profileSegments4 records
Ideal customer profiles4 records
UltraPharmRx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
UltraPharmRx partnerships and signals
Strategic signalScale indicators4 records
Recent moves4 records
Expansion highlights5 records
UltraPharmRx competitors and assessment
Company assessmentEmerging players
- Alpha Male Plus: Smaller DTC men's wellness brand offering telehealth consultations and ED/hair loss treatments. Comparable as a niche men's health telehealth competitor with overlapping product categories and subscription model.
- Marek Health: Direct-to-consumer men's health platform focused on testosterone replacement therapy, hormone optimization, and ED treatment via telehealth. Comparable in men's health telehealth focus, particularly in upcoming testosterone category UltraPharmRx lists as "Coming Soon."
Direct peers
- Ro: Direct-to-consumer telehealth company (formerly Roman) offering prescription ED, hair loss, testosterone, and weight loss treatments online with home delivery. Closely aligned on men's health focus, asynchronous intake, and subscription model.
- BlueChew: DTC telehealth company selling chewable sildenafil and tadalafil subscriptions for erectile dysfunction. Comparable in target customer, telehealth prescribing, subscription model, and narrow product focus on generic ED medications.
- K Health: AI-driven DTC telehealth platform offering online consultations, prescriptions, and treatment for primary care, mental health, and select men's health conditions. Comparable as a virtual care prescribing platform with subscription pricing.
- Lemonaid Health: Telehealth platform offering online consultations and prescription delivery for a range of conditions including ED and hair loss. Comparable as a DTC telehealth prescribing service with mail-order pharmacy fulfillment.
- Hims & Hers Health: Public direct-to-consumer telehealth platform offering prescription treatments for ED, hair loss, and other men's and women's health conditions via online consultations. Directly comparable in target customer, business model (subscription prescriptions via telehealth), and product categories.
- RexMD: Direct-to-consumer telehealth platform focused on men's sexual health, offering ED, hair loss, and testosterone treatments via online consultation. Closely comparable in customer segment, prescribing model, and subscription-based recurring revenue.
Broad incumbents
- GoodRx: Public digital pharmacy platform offering prescription discount pricing and telehealth consultations for a broad range of conditions. Comparable as a digital medication access and telehealth channel, but broader in scope than UltraPharmRx's men's health focus.
- Nurx: DTC telehealth platform providing prescription delivery for sexual health, dermatology, and primary care. Comparable as a subscription telehealth prescribing platform, but with broader category coverage than UltraPharmRx's men's health niche.
Market position
Strengths2 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights6 records
Customer concentration
UltraPharmRx social profiles
Digital presenceUltraPharmRx compliance and trust
Trust signalCompliance4 records
UltraPharmRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
UltraPharmRx leadership team
Management profileNumber of profiles
UltraPharmRx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
UltraPharmRx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about UltraPharmRx
What does UltraPharmRx do?
UltraPharmRx is a direct-to-consumer telehealth platform that connects patients in the United States with US-licensed, board-certified physicians for online consultations and prescription treatments focused on men's health conditions, including erectile dysfunction, hair loss, and low testosterone. Customers complete a 3-minute online health questionnaire, receive physician review, and obtain FDA-approved generic medications that are dispensed by a US-based pharmacy and shipped directly to their homes. Custom Fixed-Dose Combination (FDC) medications are developed exclusively for UltraPharmRx customers to target multiple treatment pathways.
Is UltraPharmRx a public or private company?
UltraPharmRx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was UltraPharmRx founded?
UltraPharmRx was founded in 2010. It employs 11 to 50 people.
Where is UltraPharmRx based?
UltraPharmRx is headquartered in Massapequa Park, United States, in the North America region.
How does UltraPharmRx make money?
Two revenue lines are on record. Prescription Medication Sales are the primary driver. The others are custom Treatment Plans.
Who are UltraPharmRx's main competitors?
Emerging players on record are Alpha Male Plus and Marek Health. Direct peers are Ro, BlueChew, K Health, Lemonaid Health, Hims & Hers Health and RexMD. Broad incumbents are GoodRx and Nurx.
Does UltraPharmRx have an API?
No public API is recorded for UltraPharmRx.
What industry is UltraPharmRx in?
UltraPharmRx's product category is Telehealth Men's Health Services. Its primary akta.pro industry code is HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs), with a secondary code of HLALAIAG, Medication Adherence & Therapy Management Platforms (refills, reminders, MTM). Its NAICS code is 62111 and its SIC code is 8011.